Navigation Links
Cedars-Sinai scientists, physicians to be key presenters at World Stem Cell Summit
Date:9/29/2011

LOS ANGELES (Sept. 29, 2011) Six leaders in stem cell research from the Cedars-Sinai Regenerative Medicine Institute will be key presenters at the world's largest interdisciplinary stem cell meeting Oct. 3-5 in Pasadena, Calif.

The World Stem Cell Summit, co-sponsored by the Cedars-Sinai Regenerative Medicine Institute, is the flagship event for the global stem cell and regenerative medicine community.

The Summit will feature more than 170 scientists, physicians, medical ethicists, legal scholars and technology transfer experts discussing the latest scientific discoveries, business models, legal and regulatory solutions and best practices. The event is expected to attract more than 1,500 attendees from 25 nations and 60 exhibitors.

Cedars-Sinai faculty members scheduled to present include:

  • Shlomo Melmed, MD, FRCP, dean of the faculty of Cedars-Sinai Medical Center and the Helene A. and Philip E. Hixon Chair in Investigative Medicine who will give the Summit's Welcome Overview at 8 a.m. Monday, Oct. 3.

  • Clive Svendsen, PhD, director of Cedars-Sinai Regenerative Medicine Institute, who will update attendees on his work into causes and treatments for amyotrophic lateral sclerosis (ALS), Parkinson's disease and other neurological disorders at 11 a.m., Wednesday, Oct. 5.

  • Leon Fine, MD, chair of Biomedical Sciences for the Medical Center will speak about Hospital and Clinical Perspectives on Stem Cells and Regenerative Medicine at 2 p.m., Wednesday, Oct. 5.

  • Charles F. Simmons Jr., MD, chair of the Cedars-Sinai Department of Pediatrics and the Ruth and Harry Roman Chair in Neonatology in honor of Larry Brown will moderate a discussion, The Outlook for the Cord Blood: All Things Considered, at 4 p.m., Monday, Oct. 3.

  • Eduardo Marbn, MD, PhD, director of the Cedars-Sinai Heart Institute and the Mark S. Siegel FamilyProfessor will present a session on Translational and Clinical Studies of Stem Cells for Heart Regeneration at 4 p.m., Monday, Oct. 3.

  • Nissim Benvenisty, MD, PhD, a research scientist at the Institute who primarily works with embryonic stem cells, will participate in a panel discussion, Safety Issues in Stem Cell Therapies, at 12:15 p.m., Tuesday, Oct. 4.

"Cedars-Sinai is proud to sponsor this unique and outstanding event that brings together industry, academia and patient advocates to discuss the real advances and challenges of stem cells and translational medicine,'' said Clive Svendsen, PhD, director of Cedars-Sinai's Regenerative Medicine Institute.

Dedicated to advancing one of the most promising medical frontiers, the Cedars-Sinai Regenerative Medicine Institute brings together basic scientists and clinicians to translate laboratory discoveries into effective stem cell and other regenerative therapies. It houses leading experts in neurodegenerative, metabolic, skeletal, blood and eye diseases under one roof with shared equipment and other resources.

At the heart of the Institute is a core facility for the production of pluripotent stem cells capable of making all tissues in the human body. These are generated from adult human patient skin biopsies and other tissues. These cells have the potential to both model and treat many different types of human diseases. Working directly with collaborators across Cedars-Sinai Medical Center the Institute's scientists are untangling the causes of disease and at the same time generating cells that may one day be used to treat patients.

"The unique combination of an outstanding hospital and rapidly growing research mission at Cedars-Sinai puts it at the cutting edge of the expanding field of regenerative medicine. We plan to move therapies from "bench to bedside" by taking them out of the laboratory and directly into the clinical environment," Svendsen said.

Led by renowned stem cell scientist Svendsen, the Institute already has received a number of grants from both the National Institutes of Health and the California Institute for Regenerative Medicine and the U.S. Department of Defense.


'/>"/>

Contact: Sally Stewart
sally.steward@cshs.org
310-248-6566
Cedars-Sinai Medical Center
Source:Eurekalert

Related medicine news :

1. Cedars-Sinai movement disorders expert on international task force for dystonia treatment
2. Latest data from Cedars-Sinai vaccine study supports immune targeting of brain tumors
3. Cedars-Sinais mobile medical clinics receive $500,000 grant from California Community Foundation
4. Cedars-Sinai to hold first annual conference on stem cell therapies for neurological disorders
5. Cedars-Sinais mobile medical clinics receive grant from George Hoag Family Foundation
6. Cedars-Sinai research team awarded $1.9 million from CIRM to develop new tools and technologies
7. Cedars-Sinai Medical Genetics Institute director honored with lifetime achievement award
8. Cedars-Sinai nano-drug hits brain-tumor target found in 2001
9. Cedars-Sinai awarded $1.9 million from CIRM to develop stem cell treatments for osteoporosis
10. Cedars-Sinai Pathology and Laboratory Medicine chair recognized with 2 of the fields top honors
11. Adults demonstrate modified immune response after receiving massage, Cedars-Sinai researchers show
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... CA (PRWEB) , ... February 24, 2017 , ... ... for qualifying into the Senior International Elite division on February 12th. Ms. ... Around divisions at the elite qualifier competition held in Las Vegas, Nevada. Frida ...
(Date:2/23/2017)... ... 2017 , ... The 89th Academy Awards will be celebrated this weekend, which ... Center Bunkum Award. We invite you to enjoy our 11th annual tongue-in-cheek “salute” to ... the Center for American Progress (CAP), for its report, Lessons From State Performance on ...
(Date:2/23/2017)... ... ... Los Angeles-based weight loss surgeon Michael Feiz, M.D., F.AC.S. will be appearing ... which will begin airing on February 24, 2017. The show chronicles the weight loss ... television series, “Here Comes Honey Boo Boo.” The earlier series from TLC lasted for ...
(Date:2/23/2017)... Los Angeles, California (PRWEB) , ... February 23, ... ... for Global Sports Development will host a diverse symposium on “Doping ... School of Law and Sheppard Mullin Richter & Hampton LLP. The symposium will ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... it will soon begin franchising throughout the U.S. starting this spring. Current Meditation ... the practice of meditation mainstream. Current Meditation will be the first meditation concept ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... , Feb. 23, 2017  Directors from Pharma To Market ... companies have joined forces, resulting in the founding of Pharma To ... Pharma To Market are pleased to announce their expansion into ... in Singapore . The company are delighted to ... Co-Director of the Singapore based entity. Joelle ...
(Date:2/24/2017)... , Feb. 23, 2017 Non-alcoholic ... on the various drugs being developed for ... all the drugs that are in various ... The pipeline focuses on novel pharmacologic drugs ... stem cell therapies, recombinant proteins and RNA-based ...
(Date:2/24/2017)... STOCKHOLM , Feb 24, 2017 ... Nomination Committee,s proposal for a new Board of Directors ... Meeting. The 2016-2017 Nomination Committee comprises representatives of the ... third quarter of 2016 who have accepted a seat ... Board. The composition of the 2016-2017 Nomination Committee was ...
Breaking Medicine Technology: